-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_executive.pdf
March 01, 2011 - Layout 1
Oral Diabetes Medications for Adults With
Type 2 Diabetes. An Update
Executive Summary
Effective Health Care
Comparative Effectiveness Review
Number 27
Effective
Health Care
Background
Type 2 diabetes is a common chronic
illness characterized by insulin resistance
and eventually by decreased insulin
…
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_4-user-guide-to-ocer_130129.pdf
January 01, 2010 - 45
Abstract
Characterization of exposure is a central issue in the analysis of observational data; however, no “one
size fits all” solution exists for exposure measurement. In this chapter, we discuss potential exposure
measurement approaches for observational comparative effectiveness research (CER). First, it is …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-function_disposition-comments.pdf
August 11, 2014 - Disposition of Comments Report for Cardiac Troponins Used as Diagnostic and Prognostic Tests in Patients Wtih Kidney Disease
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title: Cardiac Troponins Used as Diagnostic and Prognostic Tests in
Patients With Kidney Disease
…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_executive.pdf
September 01, 2009 - Layout 1
Background
Over 28 million Americans have some
form of cardiovascular disease (CVD),
which causes more deaths than cancer,
diabetes, accidents, and chronic lung
diseases combined. Estimated direct
medical expenditures and lost productivity
from CVD amounted to $431.8 billion in
the United States in 2007.
…
-
effectivehealthcare.ahrq.gov/sites/default/files/vte-protocol-8-4-10.pdf
February 01, 2008 - Bivalirudin
(Angiomax®)
The Medicines
Company
Anticoagulant in patients with unstable angina
undergoing
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/blood-clots-hip-knee-surgery_research-protocol.pdf
February 01, 2008 - Bivalirudin
(Angiomax®)
The Medicines
Company
Anticoagulant in patients with unstable angina
undergoing
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1306.pdf
October 01, 2014 - the phase III BROADEN (Brodmann Area 25 Deep
Brain Neurostimulation).19 According to a July 2011 company
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-stents-outcomes_research.pdf
January 01, 2010 - this manuscript
Bradley Hammill: None
Lesley Curtis: Research support from Allergan, Eli Lilly and Company
-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1506.pdf
June 01, 2015 - sponsors a patient savings program covering
multiple annual Evzio prescriptions.12
Kaléo is a private company
-
effectivehealthcare.ahrq.gov/sites/default/files/suppl-1-user-guide-to-ocer_130129.pdf
January 01, 2011 - Boston: Houghton
Mifflin Company; 2002.
12. Atkins D, Chang SM, Gartlehner G, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/deliberative-methods-demonstration-executive-131125.pdf
November 01, 2013 - They initially defined society as the government or a health insurance company—
4
perceiving
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/study-design-classification_research.pdf
December 01, 2010 - New York, NY:
Houghton Mifflin Company; 2002.
22. Vandenbroucke JP.
-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1312.pdf
December 01, 2013 - PEPTIC ULCER #11
AHRQ Healthcare Horizon Scanning System – Potential
High-Impact Interventions Report
Priority Area 11: Peptic Ulcer Disease and Dyspepsia
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither Road
Rockville, MD 20850
ww…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-survivor-care-transition_disposition-comments.pdf
March 18, 2014 - The medical home example is deleted,
Insurance company statement is based on KI comments
and is retained
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-bias-individual-studies_methods.pdf
March 01, 2012 - Boston: Houghton Mifflin
Company; 1979.
24. Guyatt GH, Oxman AD, Vist GE, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cognitive-decline-disposition-170707pdf.pdf
March 24, 2017 - at a public reference library for computerized cognitive
training publications that is hosted by a company
-
effectivehealthcare.ahrq.gov/sites/default/files/cognitive-decline-disposition-170707pdf.pdf
March 24, 2017 - at a public reference library for computerized cognitive
training publications that is hosted by a company
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ced-topic-refinement.pdf
November 01, 2022 - We included a representative of a healthcare technology company that
delivers evidence to biopharma companies
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/kidney-disease-medicine_research-protocol.pdf
November 01, 2010 - Evidence Report on the
Source: www.effectivehealthcare.ahrq.gov
Published Online: July 28, 2010
Evidence-based Practice Center Systematic Review Protocol
Project Title: Screening for and Management of Chronic Kidney
Disease Stages 1-3
I. Background and Objectives for the Systematic Review
T…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-prevention_research-protocol.pdf
November 03, 2011 - Evidence-based Practice Center Systematic Review Protocol
1
Source: www.effectivehealthcare.ahrq.gov
Published Online: November 3, 2011
Evidence-based Practice Center Systematic Review Protocol
Project Title: Comparative Effectiveness of Preventive Pharmacological Treatments for
Migraine
I. Backgrou…